Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jeffrey Browning
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Genes & Molecular Sequences
Concepts & Ideas
Anatomy
Physiology
Sign-in to see full Profile
Network (preview)
16
Mackay, Fabienne
13
Lawton, P
9
Ambrose, Christine
8
Hession, Cathy
8
Hochman, Paula
7
Benjamin, Christopher
7
Ngam-Ek, Apinya
7
Pepinsky, Blake
7
Rennert, Paul
7
Schneider, Pascal
7
Tschopp, Jürg
7
Ware, Carl
6
Sizing, Irene
5
Zafari, Mohammad
5
Meier, Werner
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jeffrey Browning (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Browning Jeffrey L
Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease.
Immunological reviews 2008;223():202-20.
-
2005: Browning Jeffrey L; Allaire Norm; Ngam-Ek Apinya; Notidis Evangelia; Hunt Jane; Perrin Steven; Fava Roy A
Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function.
Immunity 2005;23(5):539-50.
-
2005: Shao Zhaohui; Browning Jeffrey L; Lee Xinhua; Scott Martin L; Shulga-Morskaya Sveltlana; Allaire Norm; Thill Greg; Levesque Melissa; Sah Dinah; McCoy John M; Murray Beth; Jung Vincent; Pepinsky R Blake; Mi Sha
TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
Neuron 2005;45(3):353-9.
-
2003: Gommerman Jennifer L; Giza Keith; Perper Stuart; Sizing Irene; Ngam-Ek Apinya; Nickerson-Nutter Cheryl; Browning Jeffrey L
A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.
The Journal of clinical investigation 2003;112(5):755-67.
-
2003: Gommerman Jennifer L; Browning Jeffrey L
Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.
Nature reviews. Immunology 2003;3(8):642-55.
-
2003: Fava Roy A; Notidis Evangelia; Hunt Jane; Szanya Veronika; Ratcliffe Nora; Ngam-Ek Apinya; De Fougerolles Antonin R; Sprague Andrew; Browning Jeffrey L
A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(1):115-26.
-
2002: Wilson C A; Browning J L
Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis.
Cell death and differentiation 2002;9(12):1321-33.
-
2002: Gommerman Jennifer L; Mackay Fabienne; Donskoy Elina; Meier Werner; Martin Pauline; Browning Jeffrey L
Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway.
The Journal of clinical investigation 2002;110(9):1359-69.
-
2002: Mackay Fabienne; Browning Jeffrey L
BAFF: a fundamental survival factor for B cells.
Nature reviews. Immunology 2002;2(7):465-75.
-
2002: Browning Jeffrey L; French Lars E
Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(10):5079-87.
-
2001: Thompson J S; Bixler S A; Qian F; Vora K; Scott M L; Cachero T G; Hession C; Schneider P; Sizing I D; Mullen C; Strauch K; Zafari M; Benjamin C D; Tschopp J; Browning J L; Ambrose C
BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.
Science (New York, N.Y.) 2001;293(5537):2108-11.
-
2001: Dohi T; Rennert P D; Fujihashi K; Kiyono H; Shirai Y; Kawamura Y I; Browning J L; McGhee J R
Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(5):2781-90.
-
2001: Rennert P D; Hochman P S; Flavell R A; Chaplin D D; Jayaraman S; Browning J L; Fu Y X
Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice.
The Journal of experimental medicine 2001;193(11):1227-38.
-
2000: Rennert P; Schneider P; Cachero T G; Thompson J; Trabach L; Hertig S; Holler N; Qian F; Mullen C; Strauch K; Browning J L; Ambrose C; Tschopp J
A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth.
The Journal of experimental medicine 2000;192(11):1677-84.
-
2000: Batten M; Groom J; Cachero T G; Qian F; Schneider P; Tschopp J; Browning J L; Mackay F
BAFF mediates survival of peripheral immature B lymphocytes.
The Journal of experimental medicine 2000;192(10):1453-66.
-
2000: Thompson J S; Schneider P; Kalled S L; Wang L; Lefevre E A; Cachero T G; MacKay F; Bixler S A; Zafari M; Liu Z Y; Woodcock S A; Qian F; Batten M; Madry C; Richard Y; Benjamin C D; Browning J L; Tsapis A; Tschopp J; Ambrose C
BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population.
The Journal of experimental medicine 2000;192(1):129-35.
-
1999: Mackay F; Woodcock S A; Lawton P; Ambrose C; Baetscher M; Schneider P; Tschopp J; Browning J L
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.
The Journal of experimental medicine 1999;190(11):1697-710.
-
1999: Schneider P; MacKay F; Steiner V; Hofmann K; Bodmer J L; Holler N; Ambrose C; Lawton P; Bixler S; Acha-Orbea H; Valmori D; Romero P; Werner-Favre C; Zubler R H; Browning J L; Tschopp J
BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.
The Journal of experimental medicine 1999;189(11):1747-56.
-
1999: Marshall W L; Brinkman B M; Ambrose C M; Pesavento P A; Uglialoro A M; Teng E; Finberg R W; Browning J L; Goldfeld A E
Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(10):6016-23.
-
1998: Mackay F; Browning J L; Lawton P; Shah S A; Comiskey M; Bhan A K; Mizoguchi E; Terhorst C; Simpson S J
Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis.
Gastroenterology 1998;115(6):1464-75.
-
1998: Mackay F; Browning J L
Turning off follicular dendritic cells.
Nature 1998;395(6697):26-7.
-
1998: Rennert P D; James D; Mackay F; Browning J L; Hochman P S
Lymph node genesis is induced by signaling through the lymphotoxin beta receptor.
Immunity 1998;9(1):71-9.
-
1998: Gonzalez M; Mackay F; Browning J L; Kosco-Vilbois M H; Noelle R J
The sequential role of lymphotoxin and B cells in the development of splenic follicles.
The Journal of experimental medicine 1998;187(7):997-1007.
-
1997: Chicheportiche Y; Bourdon P R; Xu H; Hsu Y M; Scott H; Hession C; Garcia I; Browning J L
TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis.
The Journal of biological chemistry 1997;272(51):32401-10.
-
1997: Rennert P D; Browning J L; Hochman P S
Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization.
International immunology 1997;9(11):1627-39.
-
1997: Mackay F; Bourdon P R; Griffiths D A; Lawton P; Zafari M; Sizing I D; Miatkowski K; Ngam-ek A; Benjamin C D; Hession C; Ambrose C M; Meier W; Browning J L
Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(7):3299-310.
-
1997: Browning J L; Sizing I D; Lawton P; Bourdon P R; Rennert P D; Majeau G R; Ambrose C M; Hession C; Miatkowski K; Griffiths D A; Ngam-ek A; Meier W; Benjamin C D; Hochman P S
Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(7):3288-98.
-
1997: Cannella B; Sizing I D; Benjamin C D; Browning J L; Raine C S
Antibodies to lymphotoxin alpha (LT alpha) and LT beta recognize different glial cell types in the central nervous system.
Journal of neuroimmunology 1997;78(1-2):172-9.
-
1997: Mackay F; Majeau G R; Lawton P; Hochman P S; Browning J L
Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice.
European journal of immunology 1997;27(8):2033-42.
-
1997: Koni P A; Sacca R; Lawton P; Browning J L; Ruddle N H; Flavell R A
Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice.
Immunity 1997;6(4):491-500.
-
1997: Bodmer J L; Burns K; Schneider P; Hofmann K; Steiner V; Thome M; Bornand T; Hahne M; Schröter M; Becker K; Wilson A; French L E; Browning J L; MacDonald H R; Tschopp J
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95).
Immunity 1997;6(1):79-88.
-
1996: Rennert P D; Browning J L; Mebius R; Mackay F; Hochman P S
Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs.
The Journal of experimental medicine 1996;184(5):1999-2006.
-
1996: Ettinger R; Browning J L; Michie S A; van Ewijk W; McDevitt H O
Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(23):13102-7.
-
1996: Mackay F; Majeau G R; Hochman P S; Browning J L
Lymphotoxin beta receptor triggering induces activation of the nuclear factor kappaB transcription factor in some cell types.
The Journal of biological chemistry 1996;271(40):24934-8.
-
1996: Browning J L; Miatkowski K; Griffiths D A; Bourdon P R; Hession C; Ambrose C M; Meier W
Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins alpha and beta.
The Journal of biological chemistry 1996;271(15):8618-26.
-
1996: Browning J L; Miatkowski K; Sizing I; Griffiths D; Zafari M; Benjamin C D; Meier W; Mackay F
Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines.
The Journal of experimental medicine 1996;183(3):867-78.
-
1995: Force W R; Walter B N; Hession C; Tizard R; Kozak C A; Browning J L; Ware C F
Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(11):5280-8.
-
1995: Browning J L; Dougas I; Ngam-ek A; Bourdon P R; Ehrenfels B N; Miatkowski K; Zafari M; Yampaglia A M; Lawton P; Meier W
Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(1):33-46.
-
1995: Lawton P; Nelson J; Tizard R; Browning J L
Characterization of the mouse lymphotoxin-beta gene.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(1):239-46.
-
1995: Hochman P S; Majeau G R; Mackay F; Browning J L
Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
Journal of inflammation 1995;46(4):220-34.
-
1995: Ware C F; VanArsdale T L; Crowe P D; Browning J L
The ligands and receptors of the lymphotoxin system.
Current topics in microbiology and immunology 1995;198():175-218.
-
1994: Crowe P D; VanArsdale T L; Walter B N; Ware C F; Hession C; Ehrenfels B; Browning J L; Din W S; Goodwin R G; Smith C A
A lymphotoxin-beta-specific receptor.
Science (New York, N.Y.) 1994;264(5159):707-10.
-
1994: Santos A A; Browning J L; Scheltinga M R; Lynch E A; Brown E F; Lawton P; Chambers E; Dougas I; Benjamin C D; Dinarello C A
Are events after endotoxemia related to circulating phospholipase A2?
Annals of surgery 1994;219(2):183-92.
-
1993: Browning J L; Ngam-ek A; Lawton P; DeMarinis J; Tizard R; Chow E P; Hession C; O'Brine-Greco B; Foley S F; Ware C F
Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface.
Cell 1993;72(6):847-56.
-
1992: Ware C F; Crowe P D; Grayson M H; Androlewicz M J; Browning J L
Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(12):3881-8.
-
1992: Androlewicz M J; Browning J L; Ware C F
Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma.
The Journal of biological chemistry 1992;267(4):2542-7.
-
1991: Scott D L; White S P; Browning J L; Rosa J J; Gelb M H; Sigler P B
Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.
Science (New York, N.Y.) 1991;254(5034):1007-10.
-
1991: Browning J L; Androlewicz M J; Ware C F
Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(4):1230-7.
-
1991: Bomalaski J S; Lawton P; Browning J L
Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(11):3904-10.
-
1990: Pepinsky R B; Sinclair L K; Dougas I; Liang C M; Lawton P; Browning J L
Monoclonal antibodies to lipocortin-1 as probes for biological function.
FEBS letters 1990;261(2):247-52.
-
1990: Violette S M; King I; Browning J L; Pepinsky R B; Wallner B P; Sartorelli A C
Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma.
Journal of cellular physiology 1990;142(1):70-7.
-
1990: Browning J L; Ward M P; Wallner B P; Pepinsky R B
Studies on the structural properties of lipocortin-1 and the regulation of its synthesis by steroids.
Progress in clinical and biological research 1990;349():27-45.
-
1988: Pepinsky R B; Tizard R; Mattaliano R J; Sinclair L K; Miller G T; Browning J L; Chow E P; Burne C; Huang K S; Pratt D
Five distinct calcium and phospholipid binding proteins share homology with lipocortin I.
The Journal of biological chemistry 1988;263(22):10799-811.
-
1987: Cirino G; Flower R J; Browning J L; Sinclair L K; Pepinsky R B
Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung.
Nature 1987;328(6127):270-2.
-
1987: Browning J L; Ribolini A
Interferon blocks interleukin 1-induced prostaglandin release from human peripheral monocytes.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(9):2857-63.
-
1986: Pepinsky R B; Sinclair L K; Browning J L; Mattaliano R J; Smart J E; Chow E P; Falbel T; Ribolini A; Garwin J L; Wallner B P
Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates.
The Journal of biological chemistry 1986;261(9):4239-46.
Sign-in to see more
